KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $5.3 million.

  • Staar Surgical's Cash from Investing Activities rose 11499.11% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.3 million, marking a year-over-year increase of 36708.43%. This contributed to the annual value of -$59.2 million for FY2024, which is 17964.95% down from last year.
  • Staar Surgical's Cash from Investing Activities amounted to $5.3 million in Q3 2025, which was up 11499.11% from $25.1 million recorded in Q2 2025.
  • Staar Surgical's Cash from Investing Activities' 5-year high stood at $35.4 million during Q1 2025, with a 5-year trough of -$101.8 million in Q3 2022.
  • Over the past 5 years, Staar Surgical's median Cash from Investing Activities value was -$2.3 million (recorded in 2021), while the average stood at -$4.5 million.
  • In the last 5 years, Staar Surgical's Cash from Investing Activities crashed by 301179.35% in 2022 and then soared by 49121.7% in 2023.
  • Over the past 5 years, Staar Surgical's Cash from Investing Activities (Quarter) stood at -$4.7 million in 2021, then plummeted by 896.31% to -$46.7 million in 2022, then skyrocketed by 147.95% to $22.4 million in 2023, then tumbled by 187.02% to -$19.5 million in 2024, then surged by 127.1% to $5.3 million in 2025.
  • Its Cash from Investing Activities was $5.3 million in Q3 2025, compared to $25.1 million in Q2 2025 and $35.4 million in Q1 2025.